BSE filing, BSE: 544724. Summary written from the filing by ALFA Finder's alert engine.
Elfin Agro India Ltd: key numbers
- Share price
- ₹84.50
- Market cap
- ₹164.1 Cr
- Revenue (annual)
- ₹176.8 Cr
- Net profit (annual)
- ₹5.77 Cr
- P/E (TTM)
- 28.4×Sector 38.3×
- Promoter holding
- 72.59%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Elfin Agro India Ltd
All →Elfin Agro India Annual General Meeting
Elfin Agro India Ltd announced voting results for its Postal Ballot. Shareholders approved the resolution regarding the variation in the utilisation of IPO proceeds.
Elfin Agro India Other Announcement
Elfin Agro India Ltd filed its routine quarterly shareholding pattern for the period ended September 30, 2026, as required by regulation.
Elfin Agro India Board Meeting Outcome
Elfin Agro India Limited's Board has appointed M/s. Avnesh Jain & Co. as Cost Auditors for FY 2026-27. This routine board decision ensures compliance with cost audit requirements for the upcoming financial year.
- Execution
- FY 2026-2027
Elfin Agro India Annual General Meeting
Elfin Agro India issued a postal ballot notice for a meeting on 12 September 2026. The agenda includes a special resolution to approve variation in IPO proceeds utilisation.
Elfin Agro India Board Meeting Outcome
Elfin Agro India's board approved reallocating ₹1.15 Crore of IPO proceeds to working capital. Shareholder approval via postal ballot is required.
Elfin Agro India Board Meeting Date
Elfin Agro India Limited has scheduled a board meeting for September 9, 2026. The agenda includes approving postal ballot items, e-voting procedures, and appointing a scrutinizer.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.